Don't look back! what's that image fading from view? Pharma just sped through an unprecedented period of patent expiries, during which some $30 billion in brand revenue went over the cliff. But stay focused on the road. Another patent peak, equally scary, lies ahead

The sluggish economy, combined with what Michael Klein-rock, director, research development for the IMS Institute, calls 'an unprecedented period of patent expiries,' led to a drop in overall drug spend [...]